Seeing good counterpoints to the negative FUD lately, good work.
File this under "U" for uncertainty that both bulls and bears will speculate on:
2). I'm slowly leaning toward a P4 (vs. outright approval) for AD and thus the case to raise cash. Most likely will be announced after RETT data in July. Remember a P4 will cost big dollars to monitor everyone prescribed!!!!
I'm in the just wait and see what the data reveals before I play the approval speculation game, but great point on the cost of monitoring of a P4.
Knowing how Dr.M operated in the past by keeping $30 million on hand, I see the current situation to be similar but now Anavex will keep $140 million on hand to handle any and all future plans.